Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Postgraduate Medical Journal|January 11, 2005
Postprandial dysmetabolism and cardiovascular disease in type 2 diabetesM E Tushuizen, M Diamant, R J Heine
Nederlands Tijdschrift Voor Geneeskunde|August 5, 2004
[Cellular microparticles and blood-vessel damage. II. Functional characteristics and clinical significance]M Diamant, M E Tushuizen, A Sturk, et al.
Nederlands Tijdschrift Voor Geneeskunde|August 5, 2004
[Cellular microparticles and blood-vessel damage. I. Structure, detection and origin]M Diamant, M E Tushuizen, A Sturk, et al.
European Journal of Clinical Investigation|June 18, 2004
Cellular microparticles: new players in the field of vascular disease?M Diamant, M E Tushuizen, A Sturk, et al.
Journal of Thrombosis and Haemostasis : JTH|May 13, 2006
Two consecutive high-fat meals affect endothelial-dependent vasodilation, oxidative stress and cellular microparticles in healthy menM E Tushuizen, R Nieuwland, P G Scheffer, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 29, 2013
Compromised quality of life in patients with both Type 1 diabetes mellitus and coeliac diseaseS F Bakker, F Pouwer, M E Tushuizen, et al.
European Journal of Clinical Nutrition|June 30, 2011
Effect of three consecutive meals on the physicochemical properties of HDL and LDL in individuals with the metabolic syndrome and patients with type 2 diabetesP G Scheffer, M E Tushuizen, H P A Vermue, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|December 4, 2014
Advanced glycation end products (AGEs) and the soluble receptor for AGE (sRAGE) in patients with type 1 diabetes and coeliac diseaseS F Bakker, M E Tushuizen, E Gözütok, et al.
Nederlands Tijdschrift Voor Geneeskunde|April 9, 2020
[Non-alcoholic fatty liver disease; a full-bodied epidemic]M E Tushuizen, A G Holleboom, B G P Koot, et al.
Annals of the Rheumatic Diseases|November 19, 2009
Circulating microparticles remain associated with complement activation despite intensive anti-inflammatory therapy in early rheumatoid arthritisI C van Eijk, M E Tushuizen, A Sturk, et al.
Pageof 2